PRF Technologies (PRFX) Operating Expenses (2020 - 2024)
PRF Technologies' (PRFX) quarterly Operating Expenses came in at -$16.8 million in Q2 2024, down 634.59% YoY from $3.1 million in Q3 2023, and down 529.42% on a QoQ basis from $3.9 million in Q1 2024.
PRF Technologies (PRFX) Operating Expenses (2020 - 2024) Analysis & Trends
PRF Technologies (PRFX) has 5 years of Operating Expenses data on file, last reported at -$16.8 million in Q2 2024.
- Quarterly Operating Expenses fell 634.59% year-over-year to -$16.8 million in Q2 2024, while the trailing twelve-month figure through Dec 2025 was -$16.8 million (down 724.68% YoY) and the FY2025 annual result came in at $4.1 million, down 71.74% from the prior year.
- Operating Expenses fell to -$16.8 million in Q2 2024, from $3.9 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $15.6 million in Q4 2023 to a low of -$16.8 million in Q2 2024.
- A 5-year average of $802166.7 and a median of -$75000.0 in 2020 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2021 — Operating Expenses soared 10111.11% — and 2023, when it sank 168900.0%.
- Tracing PRFX's Operating Expenses over 5 years: stood at $2.7 million in 2020, then jumped by 202.36% to $8.1 million in 2021, then advanced by 18.21% to $9.5 million in 2022, then soared by 63.63% to $15.6 million in 2023, then plunged by 207.85% to -$16.8 million in 2024.
- The last three Operating Expenses figures came in at -$16.8 million (Q2 2024), $3.9 million (Q1 2024), and $15.6 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | PRF Technologies | 654,452.72 | -3.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -16.83 Mn |
| Mar 31, 2024 | 3.92 Mn |
| Dec 31, 2023 | 15.60 Mn |
| Sep 30, 2023 | -6.75 Mn |
| Jun 30, 2023 | 3.15 Mn |
| Mar 31, 2023 | -2.42 Mn |
| Dec 31, 2022 | 9.54 Mn |
| Sep 30, 2022 | 4,000.00 |
| Jun 30, 2022 | -359,000.00 |
| Mar 31, 2022 | -312,000.00 |
| Dec 31, 2021 | 8.07 Mn |
| Sep 30, 2021 | -622,000.00 |
| Jun 30, 2021 | 1.80 Mn |
| Mar 31, 2021 | -2.04 Mn |
| Dec 31, 2020 | 2.67 Mn |
| Sep 30, 2020 | -830,000.00 |
| Jun 30, 2020 | -18,000.00 |
| Mar 31, 2020 | -132,000.00 |